Anti-Human IL12B Recombinant Antibody(Briakinumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human IL12B Recombinant Antibody(Briakinumab)

Anti-Human IL12B Recombinant Antibody(Briakinumab)

产品编号

YR1099

别名

科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab
Catalog Number	YR1099
Molecular Name	Briakinumab
CAS Number	339308-60-0
Molecular Weight	146.5 kDa
Target	IL12B[Homo sapiens]
Antibody Isotype	IgG1 Lambda
Clonity	Monoclonal
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.
Application	FCM, IP, ELISA, Neut, FuncS
Remarks	This product is for research use only.

推荐产品

400-621-6806
614353794
周一至周五 8:30-18:00
0